Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure  D.W. Johnson, B. Pat, D.A. Vesey, Z.

Slides:



Advertisements
Similar presentations
Volume 63, Issue 2, Pages (February 2003)
Advertisements

E. Homsi, P. Janino, J.B.L. de Faria  Kidney International 
Volume 60, Issue 3, Pages (September 2001)
Volume 60, Issue 3, Pages (September 2001)
Volume 79, Issue 1, Pages (January 2011)
Volume 59, Issue 5, Pages (May 2001)
Progranulin protects against renal ischemia/reperfusion injury in mice
Volume 76, Issue 7, Pages (October 2009)
Li-Wen Lai, Kim-Chong Yong, Yeong-Hau H. Lien  Kidney International 
Volume 80, Issue 8, Pages (October 2011)
Y.-H.H. Lien, K.-C. Yong, C. Cho, S. Igarashi, L.-W. Lai 
Volume 86, Issue 1, Pages (July 2014)
Bax and Bak have critical roles in ischemic acute kidney injury in global and proximal tubule–specific knockout mouse models  Qingqing Wei, Guie Dong,
Volume 72, Issue 4, Pages (August 2007)
Volume 67, Issue 3, Pages (March 2005)
Volume 75, Issue 3, Pages (February 2009)
Genistein protects the kidney from cisplatin-induced injury
Epidermal growth factor receptor inhibition attenuates early kidney enlargement in experimental diabetes  Lesley Wassef, Darren J. Kelly, Richard E. Gilbert 
Volume 73, Issue 5, Pages (March 2008)
Volume 79, Issue 1, Pages (January 2011)
Vitamin E attenuates crystal formation in rat kidneys: Roles of renal tubular cell death and crystallization inhibitors  H.-S. Huang, J. Chen, C.-F. Chen,
Volume 70, Issue 2, Pages (July 2006)
Volume 57, Issue 6, Pages (June 2000)
Volume 73, Issue 4, Pages (February 2008)
Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury  Dong Zhou, Roderick.
Volume 82, Issue 9, Pages (November 2012)
Volume 63, Issue 2, Pages (February 2003)
Volume 59, Issue 5, Pages (May 2001)
Autophagy in proximal tubules protects against acute kidney injury
Volume 67, Issue 6, Pages (June 2005)
Role of meprin A in renal tubular epithelial cell injury
Gilbert R. Kinsey, Liping Huang, Amy L. Vergis, Li Li, Mark D. Okusa 
Volume 63, Issue 2, Pages (February 2003)
Volume 60, Issue 3, Pages (September 2001)
Volume 66, Issue 2, Pages (August 2004)
Richard A. Zager, Ali C.M. Johnson, Sherry Y. Hanson 
Ischemic and non-ischemic acute kidney injury cause hepatic damage
Volume 66, Issue 6, Pages (December 2004)
Volume 72, Issue 3, Pages (August 2007)
Tight blood pressure control decreases apoptosis during renal damage
Volume 83, Issue 3, Pages (March 2013)
Volume 56, Issue 4, Pages (October 1999)
Kenji Kasuno, Hajime Nakamura, Takahiko Ono, Eri Muso, Junji Yodoi 
Deletion of the epidermal growth factor receptor in renal proximal tubule epithelial cells delays recovery from acute kidney injury  Jianchun Chen, Jian-Kang.
Volume 73, Issue 12, Pages (June 2008)
Volume 85, Issue 1, Pages (January 2014)
Resistance to ischemic acute renal failure in the Brown Norway rat: A new model to study cytoprotection  David P. Basile, Deborah Donohoe, X.I.A. Cao,
Volume 56, Issue 2, Pages (August 1999)
Volume 56, Issue 3, Pages (September 1999)
Volume 63, Issue 5, Pages (May 2003)
Volume 58, Issue 6, Pages (December 2000)
The pathological role of Bax in cisplatin nephrotoxicity
Volume 76, Issue 7, Pages (October 2009)
Volume 75, Issue 5, Pages (March 2009)
Induction of heat shock protein 70 inhibits ischemic renal injury
Volume 65, Issue 6, Pages (June 2004)
Volume 79, Issue 2, Pages (January 2011)
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Volume 73, Issue 3, Pages (February 2008)
Volume 60, Issue 6, Pages (December 2001)
Volume 83, Issue 2, Pages (February 2013)
Protective actions of administered mesenchymal stem cells in acute kidney injury: relevance to clinical trials  Christof Westenfelder, Florian E. Togel 
Ganesan Ramesh, W. Brian Reeves  Kidney International 
Volume 70, Issue 10, Pages (November 2006)
E. Homsi, P. Janino, J.B.L. de Faria  Kidney International 
A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia–reperfusion injury  L.-W. Lai, K.-C. Yong,
Volume 85, Issue 1, Pages (January 2014)
Richard A. Zager, Ali Johnson, Sherry Hanson, Vivian Dela Rosa 
Volume 70, Issue 2, Pages (July 2006)
Volume 54, Issue 2, Pages (August 1998)
Presentation transcript:

Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure  D.W. Johnson, B. Pat, D.A. Vesey, Z. Guan, Z. Endre, G.C. Gobe  Kidney International  Volume 69, Issue 10, Pages 1806-1813 (May 2006) DOI: 10.1038/sj.ki.5000356 Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 1 Comparison of IRI injury with and without EPO and DPO. (a) and (b) are examples of the nontreated IR kidneys at 1 and 2 days, respectively. Examples of tubular epithelial cell apoptosis are arrowed. Epithelial cell desquamation, primary (occurring within the epithelium) and secondary (after loss of adhesion to basement membrane) apoptosis, luminal casts, and lytic degradation of some cells (necrosis) are present. (c and d) are IR plus EPO at 1 and 2 days, and (e) and (f) are IR plus DPO at 1 and 2 days, respectively. All demonstrate fewer apoptotic cells (examples arrowed) in the tubular epithelium, as well as fewer luminal casts. The increase in mitotic figures (m) is seen in (c and f), and is particularly apparent in (f). Kidney International 2006 69, 1806-1813DOI: (10.1038/sj.ki.5000356) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 2 Verification of apoptosis and mitosis. In (a and b), TUNEL-positive nuclei are demonstrated in the tubular epithelium and tubular lumen. Note that cells similar to those arrowed as apoptotic in (a and b) are TUNEL positive. In (d and e), examples of PCNA positivity in a control renal section (d, arrows) can be compared with the increase in the PCNA positivity in the outer medulla after IR (e, examples arrowed). This was seen with and without EPO and DPO, but more so with the EPO and DPO treatments. Negative controls for TUNEL (c) and PCNA (f) are demonstrated, and morphological examples of apoptosis (c) and mitosis (f) are arrowed in these photomicrographs. Kidney International 2006 69, 1806-1813DOI: (10.1038/sj.ki.5000356) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 3 Means±s.e. of quantified histological characteristics in the medulla and cortex. In each case, sets of bar graphs represent control animals (open bar), IR alone (IR, solid bar), IR plus EPO at T0 and T6 (full and open dot bars, respectively), and IR plus DPO at T0 and T6 (hatched and striped bars, respectively). In the outer stripe of the outer medulla (outer medulla), IR induced a significant increase in cell death (apoptosis) and mitosis (P<0.005) at all times. There was also a small but significant increase in these parameters for IR alone in some instances in the cortex (P<0.05). Both EPO and DPO, whether administered at T0 or T6, significantly ameliorated the extent of injury in the outer medulla at all times (P<0.05). In many cases, as demonstrated for cell proliferation by #, there was a significant increase in cell proliferation in the EPO- or DPO-treated animals compared with the level of proliferation in the IR-alone animals (P<0.05). Cortical proximal tubule mitotic figures were significantly increased in EPO- or DPO-treated animals with IRI at 1 and 2 days post-IR, compared with IR alone (P<0.05). Kidney International 2006 69, 1806-1813DOI: (10.1038/sj.ki.5000356) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 4 (a) EPO and (b) DPO ameliorate renal functional impairment following bilateral IRI. Rats were administered intraperitoneal vehicle, EPO (5000 U/kg), or DPO (25 μg/kg) at time of sham operation (controls) or bilateral renal artery occlusion (45 min) followed by reperfusion. Aortic blood samples were collected for determination of serum creatinine concentration at day 1, 2, 4, or 7 following IRI (N=4 per group for each time period). *P<0.05 vs vehicle-treated, sham-operated control. #P<0.05 vs vehicle-treated bilateral IRI. Kidney International 2006 69, 1806-1813DOI: (10.1038/sj.ki.5000356) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 5 Delayed administration of (a) EPO and (b) DPO ameliorates renal functional impairment following bilateral IRI. Rats were subjected to sham operation (controls) or bilateral renal artery occlusion (45 min) followed by reperfusion (IR). Intraperitoneal vehicle, EPO (5000 U/kg), or DPO (25 μg/kg) was administered 6 h after the onset of ischemia. Aortic blood samples were collected for determination of serum creatinine concentration at day 1, 2, 4, or 7 following IR (N=4 per group for each time period). *P<0.05 vs vehicle-treated, sham-operated control. #P<0.05 vs vehicle-treated bilateral IRI. Kidney International 2006 69, 1806-1813DOI: (10.1038/sj.ki.5000356) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 6 EPO and DPO administration is associated with diminished Bax expression in IRI kidneys. (a) and (b) are examples of Bax expression in the control and IR alone kidneys at 2 days, respectively and (c) and (d) are IR plus EPO, and IR plus DPO at 2 days, respectively. A bar graph of means for Bax expression is demonstrated for control animals vs IR animals with and without EPO and DPO in (e). IR caused a significant increase in Bax expression index for the IR-alone treatment (*P<0.05). and EPO and DPO treatments were associated with decreased Bax, with significance reached for the T0 DPO and the T6 EPO treatments (**P<0.05). Kidney International 2006 69, 1806-1813DOI: (10.1038/sj.ki.5000356) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 7 Western immunoblot of Bax. (a) Representative Western immunoblot of renal Bax is given for nontreated, EPO and DPO controls, IR at 24 and 48 h for the animals treated at T0 and T6. Bax expression (top band of the doublet is 22 kDa) increased with IR, was greatest at 24 h, and both EPO and DPO treatments were associated with lower Bax expression than that seen in the IR animals. Kidney International 2006 69, 1806-1813DOI: (10.1038/sj.ki.5000356) Copyright © 2006 International Society of Nephrology Terms and Conditions